Brain Tumor Diagnosis Using Machine Learning, Convolutional Neural Networks, Capsule Neural Networks and Vision Transformers, Applied to MRI: A Survey

An Integrative Framework for Healthcare Recommendation Systems: Leveraging the Linear Discriminant Wolf-Convolutional Neural Network (LDW-CNN) Model

In the evolving healthcare landscape, recommender systems have gained significant importance due to their role in predicting and anticipating a wide range of health-related data for both patients and healthcare professionals. These systems are crucial for delivering precise information while adhering to high standards of quality, reliability, and authentication. Objectives: The primary objective of this research is to address the challenge of class imbalance in healthcare recommendation systems. This is achieved by improving the prediction and diagnostic capabilities of these systems through a novel approach that integrates linear discriminant wolf (LDW) with convolutional neural networks (CNNs), forming the LDW-CNN model. Methods: The LDW-CNN model incorporates the grey wolf optimizer with linear discriminant analysis to enhance prediction accuracy. The model's performance is evaluated using multi-disease datasets, covering heart, liver, and kidney diseases. Established error metrics are used to compare the effectiveness of the LDW-CNN model against conventional methods, such as CNNs and multi-level support vector machines (MSVMs). Results: The proposed LDW-CNN system demonstrates remarkable accuracy, achieving a rate of 98.1%, which surpasses existing deep learning approaches. In addition, the model improves specificity to 99.18% and sensitivity to 99.008%, outperforming traditional CNN and MSVM techniques in terms of predictive performance. Conclusions: The LDW-CNN model emerges as a robust solution for multidisciplinary disease prediction and recommendation, offering superior performance in healthcare recommender systems. Its high accuracy, alongside its improved specificity and sensitivity, positions it as a valuable tool for enhancing prediction and diagnosis across multiple disease domains.

Exploiting K-Space in Magnetic Resonance Imaging Diagnosis: Dual-Path Attention Fusion for K-Space Global and Image Local Features

Magnetic resonance imaging (MRI) diagnosis, enhanced by deep learning methods, plays a crucial role in medical image processing, facilitating precise clinical diagnosis and optimal treatment planning. Current methodologies predominantly focus on feature extraction from the image domain, which often results in the loss of global features during down-sampling processes. However, the unique global representational capacity of MRI K-space is often overlooked. In this paper, we present a novel MRI K-space-based global feature extraction and dual-path attention fusion network. Our proposed method extracts global features from MRI K-space data and fuses them with local features from the image domain using a dual-path attention mechanism, thereby achieving accurate MRI segmentation for diagnosis. Specifically, our method consists of four main components: an image-domain feature extraction module, a K-space domain feature extraction module, a dual-path attention feature fusion module, and a decoder. We conducted ablation studies and comprehensive comparisons on the Brain Tumor Segmentation (BraTS) MRI dataset to validate the effectiveness of each module. The results demonstrate that our method exhibits superior performance in segmentation diagnostics, outperforming state-of-the-art methods with improvements of up to 63.82% in the HD95 distance evaluation metric. Furthermore, we performed generalization testing and complexity analysis on the Automated Cardiac Diagnosis Challenge (ACDC) MRI cardiac segmentation dataset. The findings indicate robust performance across different datasets, highlighting strong generalizability and favorable algorithmic complexity. Collectively, these results suggest that our proposed method holds significant potential for practical clinical applications.

Auto-segmentation of Adult-Type Diffuse Gliomas: Comparison of Transfer Learning-Based Convolutional Neural Network Model vs. Radiologists

Segmentation of glioma is crucial for quantitative brain tumor assessment, to guide therapeutic research and clinical management, but very time-consuming. Fully automated tools for the segmentation of multi-sequence MRI are needed. We developed and pretrained a deep learning (DL) model using publicly available datasets A (n = 210) and B (n = 369) containing FLAIR, T2WI, and contrast-enhanced (CE)-T1WI. This was then fine-tuned with our institutional dataset (n = 197) containing ADC, T2WI, and CE-T1WI, manually annotated by radiologists, and split into training (n = 100) and testing (n = 97) sets. The Dice similarity coefficient (DSC) was used to compare model outputs and manual labels. A third independent radiologist assessed segmentation quality on a semi-quantitative 5-scale score. Differences in DSC between new and recurrent gliomas, and between uni or multifocal gliomas were analyzed using the Mann-Whitney test. Semi-quantitative analyses were compared using the chi-square test. We found that there was good agreement between segmentations from the fine-tuned DL model and ground truth manual segmentations (median DSC: 0.729, std-dev: 0.134). DSC was higher for newly diagnosed (0.807) than recurrent (0.698) (p < 0.001), and higher for unifocal (0.747) than multi-focal (0.613) cases (p = 0.001). Semi-quantitative scores of DL and manual segmentation were not significantly different (mean: 3.567 vs. 3.639; 93.8% vs. 97.9% scoring ≥ 3, p = 0.107). In conclusion, the proposed transfer learning DL performed similarly to human radiologists in glioma segmentation on both structural and ADC sequences. Further improvement in segmenting challenging postoperative and multifocal glioma cases is needed.

A comprehensive survey on the use of deep learning techniques in glioblastoma

Glioblastoma, characterized as a grade 4 astrocytoma, stands out as the most aggressive brain tumor, often leading to dire outcomes. The challenge of treating glioblastoma is exacerbated by the convergence of genetic mutations and disruptions in gene expression, driven by alterations in epigenetic mechanisms. The integration of artificial intelligence, inclusive of machine learning algorithms, has emerged as an indispensable asset in medical analyses. AI is becoming a necessary tool in medicine and beyond. Current research on Glioblastoma predominantly revolves around non-omics data modalities, prominently including magnetic resonance imaging, computed tomography, and positron emission tomography. Nonetheless, the assimilation of omic data-encompassing gene expression through transcriptomics and epigenomics-offers pivotal insights into patients' conditions. These insights, reciprocally, hold significant value in refining diagnoses, guiding decision- making processes, and devising efficacious treatment strategies. This survey's core objective encompasses a comprehensive exploration of noteworthy applications of machine learning methodologies in the domain of glioblastoma, alongside closely associated research pursuits. The study accentuates the deployment of artificial intelligence techniques for both non-omics and omics data, encompassing a range of tasks. Furthermore, the survey underscores the intricate challenges posed by the inherent heterogeneity of Glioblastoma, delving into strategies aimed at addressing its multifaceted nature.

Modified osprey algorithm for optimizing capsule neural network in leukemia image recognition

The diagnosis of leukemia is a serious matter that requires immediate and accurate attention. This research presents a revolutionary method for diagnosing leukemia using a Capsule Neural Network (CapsNet) with an optimized design. CapsNet is a cutting-edge neural network that effectively captures complex features and spatial relationships within images. To improve the CapsNet's performance, a Modified Version of Osprey Optimization Algorithm (MOA) has been utilized. Thesuggested approach has been tested on the ALL-IDB database, a widely recognized dataset for leukemia image classification. Comparative analysis with various machine learning techniques, including Combined combine MobilenetV2 and ResNet18 (MBV2/Res) network, Depth-wise convolution model, a hybrid model that combines a genetic algorithm with ResNet-50V2 (ResNet/GA), and SVM/JAYA demonstrated the superiority of our method in different terms. As a result, the proposed method is a robust and powerful tool for diagnosing leukemia from medical images.

Role of artificial intelligence in brain tumour imaging

Artificial intelligence (AI) is a rapidly evolving field with many neuro-oncology applications. In this review, we discuss how AI can assist in brain tumour imaging, focusing on machine learning (ML) and deep learning (DL) techniques. We describe how AI can help in lesion detection, differential diagnosis, anatomic segmentation, molecular marker identification, prognostication, and pseudo-progression evaluation. We also cover AI applications in non-glioma brain tumours, such as brain metastasis, posterior fossa, and pituitary tumours. We highlight the challenges and limitations of AI implementation in radiology, such as data quality, standardization, and integration. Based on the findings in the aforementioned areas, we conclude that AI can potentially improve the diagnosis and treatment of brain tumours and provide a path towards personalized medicine and better patient outcomes.

Enhancing Automated Brain Tumor Detection Accuracy Using Artificial Intelligence Approaches for Healthcare Environments

Medical imaging and deep learning models are essential to the early identification and diagnosis of brain cancers, facilitating timely intervention and improving patient outcomes. This research paper investigates the integration of YOLOv5, a state-of-the-art object detection framework, with non-local neural networks (NLNNs) to improve brain tumor detection's robustness and accuracy. This study begins by curating a comprehensive dataset comprising brain MRI scans from various sources. To facilitate effective fusion, the YOLOv5 and NLNNs, K-means+, and spatial pyramid pooling fast+ (SPPF+) modules are integrated within a unified framework. The brain tumor dataset is used to refine the YOLOv5 model through the application of transfer learning techniques, adapting it specifically to the task of tumor detection. The results indicate that the combination of YOLOv5 and other modules results in enhanced detection capabilities in comparison to the utilization of YOLOv5 exclusively, proving recall rates of 86% and 83% respectively. Moreover, the research explores the interpretability aspect of the combined model. By visualizing the attention maps generated by the NLNNs module, the regions of interest associated with tumor presence are highlighted, aiding in the understanding and validation of the decision-making procedure of the methodology. Additionally, the impact of hyperparameters, such as NLNNs kernel size, fusion strategy, and training data augmentation, is investigated to optimize the performance of the combined model.

AI for interpreting screening mammograms: implications for missed cancer in double reading practices and challenging-to-locate lesions

Although the value of adding AI as a surrogate second reader in various scenarios has been investigated, it is unknown whether implementing an AI tool within double reading practice would capture additional subtle cancers missed by both radiologists who independently assessed the mammograms. This paper assesses the effectiveness of two state-of-the-art Artificial Intelligence (AI) models in detecting retrospectively-identified missed cancers within a screening program employing double reading practices. The study also explores the agreement between AI and radiologists in locating the lesions, considering various levels of concordance among the radiologists in locating the lesions. The Globally-aware Multiple Instance Classifier (GMIC) and Global-Local Activation Maps (GLAM) models were fine-tuned for our dataset. We evaluated the sensitivity of both models on missed cancers retrospectively identified by a panel of three radiologists who reviewed prior examinations of 729 cancer cases detected in a screening program with double reading practice. Two of these experts annotated the lesions, and based on their concordance levels, cases were categorized as 'almost perfect,' 'substantial,' 'moderate,' and 'poor.' We employed Similarity or Histogram Intersection (SIM) and Kullback-Leibler Divergence (KLD) metrics to compare saliency maps of malignant cases from the AI model with annotations from radiologists in each category. In total, 24.82% of cancers were labeled as "missed." The performance of GMIC and GLAM on the missed cancer cases was 82.98% and 79.79%, respectively, while for the true screen-detected cancers, the performances were 89.54% and 87.25%, respectively (p-values for the difference in sensitivity < 0.05). As anticipated, SIM and KLD from saliency maps were best in 'almost perfect,' followed by 'substantial,' 'moderate,' and 'poor.' Both GMIC and GLAM (p-values < 0.05) exhibited greater sensitivity at higher concordance. Even in a screening program with independent double reading, adding AI could potentially identify missed cancers. However, the challenging-to-locate lesions for radiologists impose a similar challenge for AI.

A comparative study of CNN-capsule-net, CNN-transformer encoder, and Traditional machine learning algorithms to classify epileptic seizure

INTRODUCTION

Epilepsy is a disease characterized by an excessive discharge in neurons generally provoked without any external stimulus, known as convulsions. About 2 million people are diagnosed each year in the world. This process is carried out by a neurological doctor using an electroencephalogram (EEG), which is lengthy.

METHOD

To optimize these processes and make them more efficient, we have resorted to innovative artificial intelligence methods essential in classifying EEG signals. For this, comparing traditional models, such as machine learning or deep learning, with cutting-edge models, in this case, using Capsule-Net architectures and Transformer Encoder, has a crucial role in finding the most accurate model and helping the doctor to have a faster diagnosis.

RESULT

In this paper, a comparison was made between different models for binary and multiclass classification of the epileptic seizure detection database, achieving a binary accuracy of 99.92% with the Capsule-Net model and a multiclass accuracy with the Transformer Encoder model of 87.30%.

CONCLUSION

Artificial intelligence is essential in diagnosing pathology. The comparison between models is helpful as it helps to discard those that are not efficient. State-of-the-art models overshadow conventional models, but data processing also plays an essential role in evaluating the higher accuracy of the models.

Evaluating Recalibrating AI Models for Breast Cancer Diagnosis in a New Context: Insights from Transfer Learning, Image Enhancement and High-Quality Training Data Integration

This paper investigates the adaptability of four state-of-the-art artificial intelligence (AI) models to the Australian mammographic context through transfer learning, explores the impact of image enhancement on model performance and analyses the relationship between AI outputs and histopathological features for clinical relevance and accuracy assessment. A total of 1712 screening mammograms (n = 856 cancer cases and n = 856 matched normal cases) were used in this study. The 856 cases with cancer lesions were annotated by two expert radiologists and the level of concordance between their annotations was used to establish two sets: a 'high-concordances subset' with 99% agreement of cancer location and an 'entire dataset' with all cases included. The area under the receiver operating characteristic curve (AUC) was used to evaluate the performance of Globally aware Multiple Instance Classifier (GMIC), Global-Local Activation Maps (GLAM), I&H and End2End AI models, both in the pretrained and transfer learning modes, with and without applying the Contrast Limited Adaptive Histogram Equalization (CLAHE) algorithm. The four AI models with and without transfer learning in the high-concordance subset outperformed those in the entire dataset. Applying the CLAHE algorithm to mammograms improved the performance of the AI models. In the high-concordance subset with the transfer learning and CLAHE algorithm applied, the AUC of the GMIC model was highest (0.912), followed by the GLAM model (0.909), I&H (0.893) and End2End (0.875). There were significant differences (p < 0.05) in the performances of the four AI models between the high-concordance subset and the entire dataset. The AI models demonstrated significant differences in malignancy probability concerning different tumour size categories in mammograms. The performance of AI models was affected by several factors such as concordance classification, image enhancement and transfer learning. Mammograms with a strong concordance with radiologists' annotations, applying image enhancement and transfer learning could enhance the accuracy of AI models.

Artificial Intelligence-Based Methods for Integrating Local and Global Features for Brain Cancer Imaging: Scoping Review

BACKGROUND

Transformer-based models are gaining popularity in medical imaging and cancer imaging applications. Many recent studies have demonstrated the use of transformer-based models for brain cancer imaging applications such as diagnosis and tumor segmentation.

OBJECTIVE

This study aims to review how different vision transformers (ViTs) contributed to advancing brain cancer diagnosis and tumor segmentation using brain image data. This study examines the different architectures developed for enhancing the task of brain tumor segmentation. Furthermore, it explores how the ViT-based models augmented the performance of convolutional neural networks for brain cancer imaging.

METHODS

This review performed the study search and study selection following the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. The search comprised 4 popular scientific databases: PubMed, Scopus, IEEE Xplore, and Google Scholar. The search terms were formulated to cover the interventions (ie, ViTs) and the target application (ie, brain cancer imaging). The title and abstract for study selection were performed by 2 reviewers independently and validated by a third reviewer. Data extraction was performed by 2 reviewers and validated by a third reviewer. Finally, the data were synthesized using a narrative approach.

RESULTS

Of the 736 retrieved studies, 22 (3%) were included in this review. These studies were published in 2021 and 2022. The most commonly addressed task in these studies was tumor segmentation using ViTs. No study reported early detection of brain cancer. Among the different ViT architectures, Shifted Window transformer-based architectures have recently become the most popular choice of the research community. Among the included architectures, UNet transformer and TransUNet had the highest number of parameters and thus needed a cluster of as many as 8 graphics processing units for model training. The brain tumor segmentation challenge data set was the most popular data set used in the included studies. ViT was used in different combinations with convolutional neural networks to capture both the global and local context of the input brain imaging data.

CONCLUSIONS

It can be argued that the computational complexity of transformer architectures is a bottleneck in advancing the field and enabling clinical transformations. This review provides the current state of knowledge on the topic, and the findings of this review will be helpful for researchers in the field of medical artificial intelligence and its applications in brain cancer.

Improving diagnosis and prognosis of lung cancer using vision transformers: a scoping review

BACKGROUND

Vision transformer-based methods are advancing the field of medical artificial intelligence and cancer imaging, including lung cancer applications. Recently, many researchers have developed vision transformer-based AI methods for lung cancer diagnosis and prognosis.

OBJECTIVE

This scoping review aims to identify the recent developments on vision transformer-based AI methods for lung cancer imaging applications. It provides key insights into how vision transformers complemented the performance of AI and deep learning methods for lung cancer. Furthermore, the review also identifies the datasets that contributed to advancing the field.

METHODS

In this review, we searched Pubmed, Scopus, IEEEXplore, and Google Scholar online databases. The search terms included intervention terms (vision transformers) and the task (i.e., lung cancer, adenocarcinoma, etc.). Two reviewers independently screened the title and abstract to select relevant studies and performed the data extraction. A third reviewer was consulted to validate the inclusion and exclusion. Finally, the narrative approach was used to synthesize the data.

RESULTS

Of the 314 retrieved studies, this review included 34 studies published from 2020 to 2022. The most commonly addressed task in these studies was the classification of lung cancer types, such as lung squamous cell carcinoma versus lung adenocarcinoma, and identifying benign versus malignant pulmonary nodules. Other applications included survival prediction of lung cancer patients and segmentation of lungs. The studies lacked clear strategies for clinical transformation. SWIN transformer was a popular choice of the researchers; however, many other architectures were also reported where vision transformer was combined with convolutional neural networks or UNet model. Researchers have used the publicly available lung cancer datasets of the lung imaging database consortium and the cancer genome atlas. One study used a cluster of 48 GPUs, while other studies used one, two, or four GPUs.

CONCLUSION

It can be concluded that vision transformer-based models are increasingly in popularity for developing AI methods for lung cancer applications. However, their computational complexity and clinical relevance are important factors to be considered for future research work. This review provides valuable insights for researchers in the field of AI and healthcare to advance the state-of-the-art in lung cancer diagnosis and prognosis. We provide an interactive dashboard on lung-cancer.onrender.com/ .

Brain tumor detection and screening using artificial intelligence techniques: Current trends and future perspectives

A brain tumor is an abnormal mass of tissue located inside the skull. In addition to putting pressure on the healthy parts of the brain, it can lead to significant health problems. Depending on the region of the brain tumor, it can cause a wide range of health issues. As malignant brain tumors grow rapidly, the mortality rate of individuals with this cancer can increase substantially with each passing week. Hence it is vital to detect these tumors early so that preventive measures can be taken at the initial stages. Computer-aided diagnostic (CAD) systems, in coordination with artificial intelligence (AI) techniques, have a vital role in the early detection of this disorder. In this review, we studied 124 research articles published from 2000 to 2022. Here, the challenges faced by CAD systems based on different modalities are highlighted along with the current requirements of this domain and future prospects in this area of research.

Tracking Therapy Response in Glioblastoma Using 1D Convolutional Neural Networks

BACKGROUND

Glioblastoma (GB) is a malignant brain tumour that is challenging to treat, often relapsing even after aggressive therapy. Evaluating therapy response relies on magnetic resonance imaging (MRI) following the Response Assessment in Neuro-Oncology (RANO) criteria. However, early assessment is hindered by phenomena such as pseudoprogression and pseudoresponse. Magnetic resonance spectroscopy (MRS/MRSI) provides metabolomics information but is underutilised due to a lack of familiarity and standardisation.

METHODS

This study explores the potential of spectroscopic imaging (MRSI) in combination with several machine learning approaches, including one-dimensional convolutional neural networks (1D-CNNs), to improve therapy response assessment. Preclinical GB (GL261-bearing mice) were studied for method optimisation and validation.

RESULTS

The proposed 1D-CNN models successfully identify different regions of tumours sampled by MRSI, i.e., normal brain (N), control/unresponsive tumour (T), and tumour responding to treatment (R). Class activation maps using Grad-CAM enabled the study of the key areas relevant to the models, providing model explainability. The generated colour-coded maps showing the N, T and R regions were highly accurate (according to Dice scores) when compared against ground truth and outperformed our previous method.

CONCLUSIONS

The proposed methodology may provide new and better opportunities for therapy response assessment, potentially providing earlier hints of tumour relapsing stages.

An Augmented Modulated Deep Learning Based Intelligent Predictive Model for Brain Tumor Detection Using GAN Ensemble

Brain tumor detection in the initial stage is becoming an intricate task for clinicians worldwide. The diagnosis of brain tumor patients is rigorous in the later stages, which is a serious concern. Although there are related pragmatic clinical tools and multiple models based on machine learning (ML) for the effective diagnosis of patients, these models still provide less accuracy and take immense time for patient screening during the diagnosis process. Hence, there is still a need to develop a more precise model for more accurate screening of patients to detect brain tumors in the beginning stages and aid clinicians in diagnosis, making the brain tumor assessment more reliable. In this research, a performance analysis of the impact of different generative adversarial networks (GAN) on the early detection of brain tumors is presented. Based on it, a novel hybrid enhanced predictive convolution neural network (CNN) model using a hybrid GAN ensemble is proposed. Brain tumor image data is augmented using a GAN ensemble, which is fed for classification using a hybrid modulated CNN technique. The outcome is generated through a soft voting approach where the final prediction is based on the GAN, which computes the highest value for different performance metrics. This analysis demonstrated that evaluation with a progressive-growing generative adversarial network (PGGAN) architecture produced the best result. In the analysis, PGGAN outperformed others, computing the accuracy, precision, recall, F1-score, and negative predictive value (NPV) to be 98.85, 98.45%, 97.2%, 98.11%, and 98.09%, respectively. Additionally, a very low latency of 3.4 s is determined with PGGAN. The PGGAN model enhanced the overall performance of the identification of brain cell tissues in real time. Therefore, it may be inferred to suggest that brain tumor detection in patients using PGGAN augmentation with the proposed modulated CNN technique generates the optimum performance using the soft voting approach.

Enhancing Prediction of Brain Tumor Classification Using Images and Numerical Data Features

Brain tumors, along with other diseases that harm the neurological system, are a significant contributor to global mortality. Early diagnosis plays a crucial role in effectively treating brain tumors. To distinguish individuals with tumors from those without, this study employs a combination of images and data-based features. In the initial phase, the image dataset is enhanced, followed by the application of a UNet transfer-learning-based model to accurately classify patients as either having tumors or being normal. In the second phase, this research utilizes 13 features in conjunction with a voting classifier. The voting classifier incorporates features extracted from deep convolutional layers and combines stochastic gradient descent with logistic regression to achieve better classification results. The reported accuracy score of 0.99 achieved by both proposed models shows its superior performance. Also, comparing results with other supervised learning algorithms and state-of-the-art models validates its performance.

Neural Networks for the Detection of COVID-19 and Other Diseases: Prospects and Challenges

Artificial neural networks (ANNs) ability to learn, correct errors, and transform a large amount of raw data into beneficial medical decisions for treatment and care has increased in popularity for enhanced patient safety and quality of care. Therefore, this paper reviews the critical role of ANNs in providing valuable insights for patients' healthcare decisions and efficient disease diagnosis. We study different types of ANNs in the existing literature that advance ANNs' adaptation for complex applications. Specifically, we investigate ANNs' advances for predicting viral, cancer, skin, and COVID-19 diseases. Furthermore, we propose a deep convolutional neural network (CNN) model called ConXNet, based on chest radiography images, to improve the detection accuracy of COVID-19 disease. ConXNet is trained and tested using a chest radiography image dataset obtained from Kaggle, achieving more than 97% accuracy and 98% precision, which is better than other existing state-of-the-art models, such as DeTraC, U-Net, COVID MTNet, and COVID-Net, having 93.1%, 94.10%, 84.76%, and 90% accuracy and 94%, 95%, 85%, and 92% precision, respectively. The results show that the ConXNet model performed significantly well for a relatively large dataset compared with the aforementioned models. Moreover, the ConXNet model reduces the time complexity by using dropout layers and batch normalization techniques. Finally, we highlight future research directions and challenges, such as the complexity of the algorithms, insufficient available data, privacy and security, and integration of biosensing with ANNs. These research directions require considerable attention for improving the scope of ANNs for medical diagnostic and treatment applications.

Vision transformer architecture and applications in digital health: a tutorial and survey

The vision transformer (ViT) is a state-of-the-art architecture for image recognition tasks that plays an important role in digital health applications. Medical images account for 90% of the data in digital medicine applications. This article discusses the core foundations of the ViT architecture and its digital health applications. These applications include image segmentation, classification, detection, prediction, reconstruction, synthesis, and telehealth such as report generation and security. This article also presents a roadmap for implementing the ViT in digital health systems and discusses its limitations and challenges.

Brain Tumor Classification based on Improved Stacked Ensemble Deep Learning Methods

OBJECTIVE

Brain Tumor diagnostic prediction is essential for assisting radiologists and other healthcare professionals in identifying and classifying brain tumors. For the diagnosis and treatment of cancer diseases, prediction and classification accuracy are crucial. The aim of this study was to improve ensemble deep learning models for classifing brain tumor and increase the performance of structure models by combining different model of deep learning to develop a model with more accurate predictions than the individual models.

METHODS

Convolutional neural networks (CNNs), which are made up of a single algorithm called CNN model, are the foundation of most current methods for classifying cancer illness images. The model CNN is combined with other models to create other methods of classification called ensemble method. However, compared to a single machine learning algorithm, ensemble machine learning models are more accurate. This study used stacked ensemble deep learning technology. The data set used in this study was obtained from Kaggle and included two categories: abnormal & normal brains. The data set was trained with three models: VGG19, Inception v3, and Resnet 10.

RESULT

The 96.6% accuracy for binary classification (0,1) have been achieved by stacked ensemble deep learning model with Loss binary cross entropy, and Adam optimizer take into consideration with stacking models.

CONCLUSION

The stacked ensemble deep learning model can be improved over a single framework.

Brain tumor detection and segmentation: Interactive framework with a visual interface and feedback facility for dynamically improved accuracy and trust

Brain cancers caused by malignant brain tumors are one of the most fatal cancer types with a low survival rate mostly due to the difficulties in early detection. Medical professionals therefore use various invasive and non-invasive methods for detecting and treating brain tumors at the earlier stages thus enabling early treatment. The main non-invasive methods for brain tumor diagnosis and assessment are brain imaging like computed tomography (CT), positron emission tomography (PET) and magnetic resonance imaging (MRI) scans. In this paper, the focus is on detection and segmentation of brain tumors from 2D and 3D brain MRIs. For this purpose, a complete automated system with a web application user interface is described which detects and segments brain tumors with more than 90% accuracy and Dice scores. The user can upload brain MRIs or can access brain images from hospital databases to check presence or absence of brain tumor, to check the existence of brain tumor from brain MRI features and to extract the tumor region precisely from the brain MRI using deep neural networks like CNN, U-Net and U-Net++. The web application also provides an option for entering feedbacks on the results of the detection and segmentation to allow healthcare professionals to add more precise information on the results that can be used to train the model for better future predictions and segmentations.

Grade Classification of Tumors from Brain Magnetic Resonance Images Using a Deep Learning Technique

To improve the accuracy of tumor identification, it is necessary to develop a reliable automated diagnostic method. In order to precisely categorize brain tumors, researchers developed a variety of segmentation algorithms. Segmentation of brain images is generally recognized as one of the most challenging tasks in medical image processing. In this article, a novel automated detection and classification method was proposed. The proposed approach consisted of many phases, including pre-processing MRI images, segmenting images, extracting features, and classifying images. During the pre-processing portion of an MRI scan, an adaptive filter was utilized to eliminate background noise. For feature extraction, the local-binary grey level co-occurrence matrix (LBGLCM) was used, and for image segmentation, enhanced fuzzy c-means clustering (EFCMC) was used. After extracting the scan features, we used a deep learning model to classify MRI images into two groups: glioma and normal. The classifications were created using a convolutional recurrent neural network (CRNN). The proposed technique improved brain image classification from a defined input dataset. MRI scans from the REMBRANDT dataset, which consisted of 620 testing and 2480 training sets, were used for the research. The data demonstrate that the newly proposed method outperformed its predecessors. The proposed CRNN strategy was compared against BP, U-Net, and ResNet, which are three of the most prevalent classification approaches currently being used. For brain tumor classification, the proposed system outcomes were 98.17% accuracy, 91.34% specificity, and 98.79% sensitivity.

Combining CNN Features with Voting Classifiers for Optimizing Performance of Brain Tumor Classification

Brain tumors and other nervous system cancers are among the top ten leading fatal diseases. The effective treatment of brain tumors depends on their early detection. This research work makes use of 13 features with a voting classifier that combines logistic regression with stochastic gradient descent using features extracted by deep convolutional layers for the efficient classification of tumorous victims from the normal. From the first and second-order brain tumor features, deep convolutional features are extracted for model training. Using deep convolutional features helps to increase the precision of tumor and non-tumor patient classification. The proposed voting classifier along with convoluted features produces results that show the highest accuracy of 99.9%. Compared to cutting-edge methods, the proposed approach has demonstrated improved accuracy.

Convergence of Artificial Intelligence and Neuroscience towards the Diagnosis of Neurological Disorders-A Scoping Review

Artificial intelligence (AI) is a field of computer science that deals with the simulation of human intelligence using machines so that such machines gain problem-solving and decision-making capabilities similar to that of the human brain. Neuroscience is the scientific study of the struczture and cognitive functions of the brain. Neuroscience and AI are mutually interrelated. These two fields help each other in their advancements. The theory of neuroscience has brought many distinct improvisations into the AI field. The biological neural network has led to the realization of complex deep neural network architectures that are used to develop versatile applications, such as text processing, speech recognition, object detection, etc. Additionally, neuroscience helps to validate the existing AI-based models. Reinforcement learning in humans and animals has inspired computer scientists to develop algorithms for reinforcement learning in artificial systems, which enables those systems to learn complex strategies without explicit instruction. Such learning helps in building complex applications, like robot-based surgery, autonomous vehicles, gaming applications, etc. In turn, with its ability to intelligently analyze complex data and extract hidden patterns, AI fits as a perfect choice for analyzing neuroscience data that are very complex. Large-scale AI-based simulations help neuroscientists test their hypotheses. Through an interface with the brain, an AI-based system can extract the brain signals and commands that are generated according to the signals. These commands are fed into devices, such as a robotic arm, which helps in the movement of paralyzed muscles or other human parts. AI has several use cases in analyzing neuroimaging data and reducing the workload of radiologists. The study of neuroscience helps in the early detection and diagnosis of neurological disorders. In the same way, AI can effectively be applied to the prediction and detection of neurological disorders. Thus, in this paper, a scoping review has been carried out on the mutual relationship between AI and neuroscience, emphasizing the convergence between AI and neuroscience in order to detect and predict various neurological disorders.

CNN-Based Classification for Highly Similar Vehicle Model Using Multi-Task Learning

Vehicle make and model classification is crucial to the operation of an intelligent transportation system (ITS). Fine-grained vehicle information such as make and model can help officers uncover cases of traffic violations when license plate information cannot be obtained. Various techniques have been developed to perform vehicle make and model classification. However, it is very hard to identify the make and model of vehicles with highly similar visual appearances. The classifier contains a lot of potential for mistakes because the vehicles look very similar but have different models and manufacturers. To solve this problem, a fine-grained classifier based on convolutional neural networks with a multi-task learning approach is proposed in this paper. The proposed method takes a vehicle image as input and extracts features using the VGG-16 architecture. The extracted features will then be sent to two different branches, with one branch being used to classify the vehicle model and the other to classify the vehicle make. The performance of the proposed method was evaluated using the InaV-Dash dataset, which contains an Indonesian vehicle model with a highly similar visual appearance. The experimental results show that the proposed method achieves 98.73% accuracy for vehicle make and 97.69% accuracy for vehicle model. Our study also demonstrates that the proposed method is able to improve the performance of the baseline method on highly similar vehicle classification problems.